Roger Bedimo

1.5k total citations
25 papers, 638 citations indexed

About

Roger Bedimo is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Roger Bedimo has authored 25 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Emergency Medicine and 8 papers in Epidemiology. Recurrent topics in Roger Bedimo's work include HIV-related health complications and treatments (12 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (6 papers). Roger Bedimo is often cited by papers focused on HIV-related health complications and treatments (12 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (6 papers). Roger Bedimo collaborates with scholars based in United States, Spain and Ivory Coast. Roger Bedimo's co-authors include Anthony J. Busti, Ronald G. Hall, James B Cutrell, Claudia Meek, Richard D. Leff, Reza Mehvar, Maria C. Rodriguez‐Barradas, Catherine Chirouze, Pierre Tattevin and Christopher H. Cabell and has published in prestigious journals such as Annals of Internal Medicine, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Roger Bedimo

25 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Bedimo United States 14 365 311 122 107 72 25 638
Sarah H. Sutton United States 14 294 0.8× 254 0.8× 58 0.5× 74 0.7× 82 1.1× 42 658
Javier Martínez‐Sanz Spain 18 401 1.1× 425 1.4× 98 0.8× 117 1.1× 43 0.6× 82 903
Stephen P. Storfer United States 7 635 1.7× 354 1.1× 56 0.5× 65 0.6× 44 0.6× 8 851
Ronan Boulmé France 9 245 0.7× 543 1.7× 63 0.5× 87 0.8× 27 0.4× 17 951
Antonella Santoro Italy 16 288 0.8× 256 0.8× 340 2.8× 44 0.4× 25 0.3× 51 849
Marc Foca United States 18 579 1.6× 263 0.8× 271 2.2× 149 1.4× 44 0.6× 42 1.0k
Laura Cordier United States 17 336 0.9× 120 0.4× 163 1.3× 85 0.8× 74 1.0× 37 872
Mulinda Nyirenda Malawi 15 227 0.6× 465 1.5× 150 1.2× 69 0.6× 51 0.7× 49 740
Jonathan Baghdadi United States 15 129 0.4× 228 0.7× 68 0.6× 36 0.3× 58 0.8× 43 575
Regina Osih United States 10 363 1.0× 360 1.2× 38 0.3× 61 0.6× 49 0.7× 17 702

Countries citing papers authored by Roger Bedimo

Since Specialization
Citations

This map shows the geographic impact of Roger Bedimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Bedimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Bedimo more than expected).

Fields of papers citing papers by Roger Bedimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Bedimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Bedimo. The network helps show where Roger Bedimo may publish in the future.

Co-authorship network of co-authors of Roger Bedimo

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Bedimo. A scholar is included among the top collaborators of Roger Bedimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Bedimo. Roger Bedimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizza, Stacey A., et al.. (2021). Point-of-care program in HIV, tuberculosis, and associated conditions: A virtual global technical assistance platform to strengthen HIV and tuberculosis workforce capacity. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 23. 100238–100238. 1 indexed citations
2.
Edelman, E. Jennifer, Stephen A. Maisto, Nathan B. Hansen, et al.. (2020). Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial. Addiction Science & Clinical Practice. 15(1). 28–28. 13 indexed citations
3.
Sigel, Keith, Kimberly Stone, Juan P. Wisnivesky, et al.. (2019). Short-term outcomes for lung cancer resection surgery in HIV infection. AIDS. 33(8). 1353–1360. 11 indexed citations
4.
Edelman, E. Jennifer, Stephen A. Maisto, Nathan B. Hansen, et al.. (2019). Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. The Lancet HIV. 6(8). e509–e517. 44 indexed citations
5.
Yotsu, Rie, Barbine Tchamba Agbor Agbor, Roger Bedimo, et al.. (2018). Skin disease prevalence study in schoolchildren in rural Côte d'Ivoire: Implications for integration of neglected skin diseases (skin NTDs). PLoS neglected tropical diseases. 12(5). e0006489–e0006489. 47 indexed citations
6.
Singh, Upinder, Wendy S. Armstrong, Roger Bedimo, et al.. (2018). Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce. The Journal of Infectious Diseases. 218(suppl_1). S49–S54. 10 indexed citations
7.
Bedimo, Roger. (2017). HIV and Smoking Cessation. 1 indexed citations
8.
Bedimo, Roger, Naim M. Maalouf, & Vincent Lo Re. (2016). Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Current Opinion in HIV and AIDS. 11(3). 285–293. 21 indexed citations
9.
Edelman, E. Jennifer, Stephen A. Maisto, Nathan B. Hansen, et al.. (2016). The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients. Contemporary Clinical Trials. 52. 80–90. 25 indexed citations
10.
Bedimo, Roger, et al.. (2016). Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients. Current HIV/AIDS Reports. 13(6). 328–339. 16 indexed citations
11.
12.
Bedimo, Roger, James B Cutrell, Song Zhang, et al.. (2015). Mechanisms of bone disease in HIV and hepatitis C virus. AIDS. 30(4). 601–608. 23 indexed citations
13.
Surís, Alina, et al.. (2013). Rapid HIV testing experience at Veterans Affairs North Texas Health Care System's Homeless Stand Downs. AIDS Care. 26(1). 95–99. 2 indexed citations
14.
Cutrell, James B & Roger Bedimo. (2013). Non-AIDS-defining Cancers Among HIV-Infected Patients. Current HIV/AIDS Reports. 10(3). 207–216. 26 indexed citations
15.
Bedimo, Roger. (2011). Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. HIV/AIDS - Research and Palliative Care. 3. 69–69. 12 indexed citations
16.
Nguyen, Sean, et al.. (2008). Acute elevation of triglycerides after initiation of fosamprinavir/ritonavir in an HIV-negative patient with baseline hypertriglyceridemia. Journal of clinical lipidology. 2(5). 398–400. 1 indexed citations
17.
Hall, Ronald G., et al.. (2008). Multicenter Evaluation of Vancomycin Dosing: Emphasis on Obesity. The American Journal of Medicine. 121(6). 515–518. 50 indexed citations
18.
Nguyen, Sean, et al.. (2008). Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(3). 323–330. 23 indexed citations
19.
Busti, Anthony J., Ronald G. Hall, Roger Bedimo, et al.. (2008). Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin. Journal of Cardiovascular Pharmacology. 51(6). 605–610. 81 indexed citations
20.
Morpeth, Susan C., David Murdoch, Christopher H. Cabell, et al.. (2007). Non-HACEK Gram-Negative Bacillus Endocarditis. Annals of Internal Medicine. 147(12). 829–835. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah H. Sutton Breakdown of academic impact, for papers by Javier Martínez‐Sanz Breakdown of academic impact, for papers by Stephen P. Storfer Breakdown of academic impact, for papers by Ronan Boulmé Breakdown of academic impact, for papers by Antonella Santoro Breakdown of academic impact, for papers by Marc Foca Breakdown of academic impact, for papers by Laura Cordier Breakdown of academic impact, for papers by Mulinda Nyirenda Breakdown of academic impact, for papers by Jonathan Baghdadi Breakdown of academic impact, for papers by Regina Osih
Rankless by CCL
2026